# US 2022/0025345 A1 · Rna-guided endonuclease fusion polypeptides and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0025345 A1
- Document ID: US20220025345A1
- Status: Published application
- Kind: A1
- Application number: 17/340,822
- Filed: 2021-06-07
- Published: 2022-01-27
- Earliest claimed: 2017-09-08
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Schaked Omer Halperin
- Web page: https://patentgrep.com/patent/US20220025345A1

## CPC

- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 9/1252: {DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase}
- C12N 9/78: acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N 15/1024: {In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12Y 207/07007: DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
- C12Y 305/04004: Adenosine deaminase (3.5.4.4)
- C12Y 305/04005: Cytidine deaminase (3.5.4.5)
- C12N 15/85: for animal cells
- C12N 15/90: Stable introduction of foreign DNA into chromosome
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The present disclosure provides a fusion polypeptide comprising: a) an enzymatically active RNA-guided endonuclease that introduces a single-stranded break in a target DNA; and b) an error-prone DNA polymerase. The present disclosure provides a system comprising: a) a fusion polypeptide of the present disclosure; and b) a guide RNA. The present disclosure provides a cell comprising a fusion polypeptide of the present disclosure, or a system of the present disclosure. The present disclosure provides a method of mutagenizing a target polynucleotide.

## Claims

### Claim at position 1

1-84. (canceled)

### Claim 85

A fusion polypeptide comprising:
a) an enzymatically active RNA-guided endonuclease; and
b) a DNA polymerase.

### Claim 86 (depends on 85)

The fusion polypeptide of claim 85, wherein the endonuclease comprises a nickase that introduces a single-stranded break in a target DNA.

### Claim 87 (depends on 86)

The fusion polypeptide of claim 86, wherein the DNA polymerase binds to the target DNA 5′ to the single-stranded break, and synthesizes a new strand on the target DNA.

### Claim 88 (depends on 87)

The fusion polypeptide of claim 87, wherein the DNA polymerase introduces a mutation in the target DNA.

### Claim 89 (depends on 87)

The fusion polypeptide of claim 87, wherein the fusion polypeptide, when complexed with a guide RNA, introduces a mutation at a distance of from 1 nucleotide to 104 nucleotides from the single-stranded break in the target DNA.

### Claim 90 (depends on 85)

The fusion polypeptide of claim 85, wherein the endonuclease comprises a class 2 CRISPR/Cas endonuclease.

### Claim 91 (depends on 90)

The fusion polypeptide of claim 90, wherein the class 2 CRISPR/Cas endonuclease comprises a type V or type VI CRISPR/Cas endonuclease.

### Claim 92 (depends on 90)

The fusion polypeptide of claim 90, wherein the class 2 CRISPR/Cas endonuclease comprises a Cas9 polypeptide.

### Claim 93 (depends on 85)

The fusion polypeptide of claim 85, comprising a linker connecting the endonuclease and the DNA polymerase.

### Claim 94 (depends on 85)

The fusion polypeptide of claim 85, further comprising a nuclear localization signal.

### Claim 95 (depends on 85)

A cell comprising the fusion polypeptide of claim 85.

### Claim 96 (depends on 95)

The cell of claim 95, wherein the cell comprises a prokaryotic cell.

### Claim 97 (depends on 95)

The cell of claim 95, wherein the cell comprises a eukaryotic cell.

### Claim 98

An editing system comprising:
a) an enzymatically active RNA-guided endonuclease that introduces a break in at least one strand in a target DNA;
b) a DNA polymerase that binds to the target DNA 5′ to the break; and
c) a guide RNA that binds the endonuclease;
d) wherein the endonuclease, DNA polymerase, and guide RNA are exogenously introduced into a cell, or are encoded by one or more exogenously introduced nucleic acids.

### Claim 99 (depends on 98)

The system of claim 98, wherein the guide RNA comprises a protein-binding segment comprising a nucleotide sequence that binds to the endonuclease, and a target-binding segment comprising a nucleotide sequence that is complementary to a target nucleotide sequence of the target DNA.

### Claim 100 (depends on 98)

The system of claim 98, wherein the guide RNA guides the endonuclease to introduce the break in the target DNA.

### Claim 101 (depends on 98)

The system of claim 98, wherein the break in at least one strand is a single-stranded break.

### Claim 102 (depends on 98)

The system of claim 98, wherein the endonuclease and the DNA polymerase are fused as parts of a fusion polypeptide.

### Claim 103 (depends on 98)

The system of claim 98, wherein the DNA polymerase introduces a mutation in the target DNA.

### Claim 104 (depends on 98)

The system of claim 98, wherein the endonuclease comprises a class 2 CRISPR/Cas endonuclease.

### Claim 105 (depends on 104)

The system of claim 104, wherein the class 2 CRISPR/Cas endonuclease comprises a Cas9 polypeptide.

### Claim 106 (depends on 98)

A eukaryotic or prokaryotic cell comprising the system of claim 98.

### Claim 107

An editing method comprising:
contacting a target DNA with an RNA-guided endonuclease that introduces a single-stranded break in the target DNA; and
contacting the target DNA with a DNA polymerase that binds to the target DNA 5′ to the single-stranded break, and synthesizes a new strand on the target DNA.

### Claim 108 (depends on 107)

The method of claim 107, wherein the DNA polymerase is part of a fusion polypeptide comprising the endonuclease.

### Claim 109 (depends on 108)

The method of claim 108, wherein contacting the target DNA with the DNA polymerase comprises contacting the fusion polypeptide with a guide RNA that binds the target DNA and the endonuclease.

### Claim 110 (depends on 109)

The method of claim 109, wherein the guide RNA comprises a protein-binding segment comprising a nucleotide sequence that binds to the endonuclease, and a target-binding segment comprising a nucleotide sequence that is complementary to a target nucleotide sequence of the target DNA.

### Claim 111 (depends on 107)

The method of claim 107, wherein the new strand comprises a mutation.

### Claim 112 (depends on 107)

The method of claim 107, wherein the endonuclease comprises a class 2 CRISPR/Cas endonuclease.

### Claim 113 (depends on 112)

The method of claim 112, wherein the class 2 CRISPR/Cas endonuclease comprises a Cas9 polypeptide.

### Claim 114 (depends on 107)

The method of claim 107, wherein contacting the target DNA with the endonuclease or DNA polymerase comprises introducing a nucleic acid encoding the endonuclease or DNA polymerase into a cell comprising the target DNA.
